These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2222558

  • 1. In vitro studies with the stabilized epoprostenol analogue taprostene. Effect on platelets and erythrocytes.
    Michel G, Seipp U.
    Arzneimittelforschung; 1990 Jul; 40(7):817-22. PubMed ID: 2222558
    [Abstract] [Full Text] [Related]

  • 2. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G, Seipp U.
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [Abstract] [Full Text] [Related]

  • 3. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro.
    Inoue K, Aoki Y, Kitahara S, Kiyoki M, Araki H.
    Arzneimittelforschung; 1995 Sep; 45(9):975-9. PubMed ID: 7488316
    [Abstract] [Full Text] [Related]

  • 4. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N.
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [Abstract] [Full Text] [Related]

  • 5. Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats.
    Umetsu T, Murata T, Nishio S.
    Arzneimittelforschung; 1989 Jan; 39(1):68-73. PubMed ID: 2541730
    [Abstract] [Full Text] [Related]

  • 6. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
    Katsube N, Sakaguchi K, Fujitani B, Aishita H.
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
    [Abstract] [Full Text] [Related]

  • 7. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S.
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [Abstract] [Full Text] [Related]

  • 8. Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.
    Chen YY, Kwan CY, Hui SC.
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):105-8. PubMed ID: 9772654
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T, Satoh K, Nishimura T, Horikawa N, Mine T, Hirohashi T, Hara Y.
    Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
    [Abstract] [Full Text] [Related]

  • 10. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
    Zhang M, Zhang LZ, Lu JS.
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological properties of the novel anti-platelet aggregating agent 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid.
    Fujimori T, Harada K, Saeki T, Kogushi M, Akasaka K, Yamagishi Y, Yamatsu I.
    Arzneimittelforschung; 1987 Oct; 37(10):1143-8. PubMed ID: 3124862
    [Abstract] [Full Text] [Related]

  • 12. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets.
    Aoki Y, Inoue K, Kitahara S, Kiyoki M, Araki H.
    Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315
    [Abstract] [Full Text] [Related]

  • 13. Small aggregates of platelets can be detected sensitively by a flow cytometer equipped with an imaging device: mechanisms of epinephrine-induced aggregation and antiplatelet effects of beraprost.
    Satoh K, Yatomi Y, Kubota F, Ozaki Y.
    Cytometry; 2002 Aug 01; 48(4):194-201. PubMed ID: 12210143
    [Abstract] [Full Text] [Related]

  • 14. Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.
    Sim AK, McCraw AP, Cleland ME, Nishio S, Umetsu T.
    Arzneimittelforschung; 1985 Aug 01; 35(12):1816-8. PubMed ID: 3913423
    [Abstract] [Full Text] [Related]

  • 15. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU, Förster W, Heinroth I.
    Arzneimittelforschung; 1982 Aug 01; 32(3):189-94. PubMed ID: 6896278
    [Abstract] [Full Text] [Related]

  • 16. In vitro antiplatelet activity of the carbinol analogue of ketoprofen, 3-(1-methyl-2-hydroxyethyl)-benzophenone.
    Oshima K, Hashizume H, Miyamae T, Morikawa T, Hagiwara M.
    Arzneimittelforschung; 1996 Jul 01; 46(7):691-3. PubMed ID: 8842339
    [Abstract] [Full Text] [Related]

  • 17. [Effect of protopine on rabbit platelet function].
    Ma GY, Zhang ZZ, Chen ZH.
    Zhongguo Yao Li Xue Bao; 1994 Jul 01; 15(4):367-71. PubMed ID: 7801784
    [Abstract] [Full Text] [Related]

  • 18. Synergistic actions of prostacyclin and an isoquinoline derivative (CH-102) on ADP-induced aggregation of dog platelets in vitro.
    Pataricza J, Bor P, Szekeres L.
    Biomed Biochim Acta; 1984 Jul 01; 43(12):1365-9. PubMed ID: 6398698
    [Abstract] [Full Text] [Related]

  • 19. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD, Kinlough-Rathbone RL, Mustard JF.
    J Lab Clin Med; 1986 Feb 01; 107(2):148-53. PubMed ID: 3080538
    [Abstract] [Full Text] [Related]

  • 20. Effects of lidocaine, codeine and vadocaine hydrochloride on platelet aggregation in human platelet-rich plasma.
    Kangasaho M.
    Arzneimittelforschung; 1988 Apr 01; 38(4A):613-6. PubMed ID: 2840087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.